1. Home
  2. LPCN vs AGMH Comparison

LPCN vs AGMH Comparison

Compare LPCN & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • AGMH
  • Stock Information
  • Founded
  • LPCN 1997
  • AGMH 2015
  • Country
  • LPCN United States
  • AGMH Hong Kong
  • Employees
  • LPCN N/A
  • AGMH N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • AGMH EDP Services
  • Sector
  • LPCN Health Care
  • AGMH Technology
  • Exchange
  • LPCN Nasdaq
  • AGMH Nasdaq
  • Market Cap
  • LPCN 18.2M
  • AGMH 17.1M
  • IPO Year
  • LPCN N/A
  • AGMH 2018
  • Fundamental
  • Price
  • LPCN $3.19
  • AGMH $6.79
  • Analyst Decision
  • LPCN Strong Buy
  • AGMH
  • Analyst Count
  • LPCN 1
  • AGMH 0
  • Target Price
  • LPCN $8.00
  • AGMH N/A
  • AVG Volume (30 Days)
  • LPCN 45.3K
  • AGMH 11.4M
  • Earning Date
  • LPCN 11-06-2025
  • AGMH 11-18-2025
  • Dividend Yield
  • LPCN N/A
  • AGMH N/A
  • EPS Growth
  • LPCN N/A
  • AGMH N/A
  • EPS
  • LPCN N/A
  • AGMH 6.43
  • Revenue
  • LPCN $4,208,119.00
  • AGMH $32,044,575.00
  • Revenue This Year
  • LPCN N/A
  • AGMH N/A
  • Revenue Next Year
  • LPCN N/A
  • AGMH N/A
  • P/E Ratio
  • LPCN N/A
  • AGMH $0.97
  • Revenue Growth
  • LPCN N/A
  • AGMH N/A
  • 52 Week Low
  • LPCN $2.65
  • AGMH $1.09
  • 52 Week High
  • LPCN $6.17
  • AGMH $107.50
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 63.61
  • AGMH 57.88
  • Support Level
  • LPCN $2.65
  • AGMH $6.70
  • Resistance Level
  • LPCN $3.52
  • AGMH $9.49
  • Average True Range (ATR)
  • LPCN 0.16
  • AGMH 1.97
  • MACD
  • LPCN 0.06
  • AGMH -0.15
  • Stochastic Oscillator
  • LPCN 67.24
  • AGMH 6.40

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is an integrated technology company. The company focuses on blockchain-oriented ASIC chip design, high-end crypto miner production, and fintech technology software services. The company generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

Share on Social Networks: